Automated Immunoassay Analyzers Market Size, Share, Trends, Growth and Forecast 2030

Automated Immunoassay Analyzers Industry Perspective:    

The global automated immunoassay analyzers market size was evaluated at $15.1 billion in 2022 and is slated to hit $20.2 billion by the end of 2030 with a CAGR of nearly 16.1% between 2023 and 2030.

Request Free Sample

Automated Immunoassay Analyzers Market: Overview

Automated Immunoassay is a method that can be utilized for determining the existence of a specific substance in the human body. The substance can be in the form of antigen, hormone, pathogen, enzyme, or antibody. Furthermore, immunoassay depends on the principle of antibody & antigen specificity. Apart from this, automated immunoassays are used extensively in clinical diagnostics, clinical chemistry, and quality control in food & beverages, pharma, and biotech sectors.       

Key Insights

• As per the analysis shared by our research analyst, the global automated immunoassay analyzers market is projected to expand annually at the annual growth rate of around 16.1% over the forecast timespan (2023-2030)
• In terms of revenue, the global automated immunoassay analyzers size market was evaluated at nearly $15.1 billion in 2022 and is expected to reach $20.2 billion by 2030.
• The global automated immunoassay analyzers market is anticipated to record massive growth over the forecast period owing to the rapidly surging old-age population prone to contagious ailments, which has resulted in the conducting of a large number of diagnostic tests prompting the demand for automated immunoassay analyzers.
• In terms of technology, the chemiluminescence immunoassay (CLIA) segment is slated to register the fastest CAGR over the analysis period.
• Based on the end-user, the hospital segment is predicted to lead the segmental surge over the forecast timeline.
• Region-wise, the Asia-Pacific automated immunoassay analyzers market is projected to register the highest CAGR during the assessment timeline.

Request Free Sample

Automated Immunoassay Analyzers Market: Growth Factors

Increase in the geriatric population susceptible to chronic disorders to boost the global market trends

The rapidly surging old-age population prone to contagious ailments has resulted in the conducting of a large number of diagnostic tests. This has prompted the demand for automated immunoassay analyzers, thereby steering the market trends. In addition to this, preventive healthcare as well as lab automation and their integration are a few of the aspects that will embellish the expansion of the automated immunoassay analyzers industry over the forthcoming years. New product launches are predicted to contribute lucratively towards the global market size in the coming years. In May 2023, Beckman Coulter, a key firm in the clinical diagnostics sector, launched the Dxl 9000 Access Immunoassay Analyzer. For the record, the medical device can run nearly 215 tests each hour per square meter.

Apparently, the escalating demand for global standardization and comparability of the outcomes will enhance the popularity of automated immunoassay analyzers in the years ahead. Additionally, the breakthroughs witnessed in biotechnology and huge funding of research activities in the biochemistry, bio-medical, and pharma fields will augment the industry size during the forecast timeline. Moreover, the rise in the occurrence of chronic ailments and pandemics like COVID-19 and the improvement in healthcare amenities witnessed in developing nations will fuel the market elevation in the years to come.  

Automated Immunoassay Analyzers Market: Restraints

Low availability of skilled personnel can put brakes on the global industry expansion over 2023-2030

The lack of availability of qualified professionals in the healthcare sector can create impediments in the growth path of the global automated immunoassay analyzers market. Moreover, a lack of awareness about the benefits provided by medical devices in emerging economies can further retard global industry expansion.  

Automated Immunoassay Analyzers Market: Opportunities

Rise in product penetration in various end-use sectors to generate new growth opportunities for the global market

Growing demand for the product owing to its high-throughput and inherent specificity will open new growth avenues for the global automated immunoassay analyzers market. Apart from this, massive penetration of products in pharmaceutical, food & beverages, and biotechnology sectors will prop up the scope of the global market in the years ahead.    

Automated Immunoassay Analyzers Market: Challenges

Easy access to substitute products at reduced costs can be a great challenge for the global industry expansion by 2023

Easy availability of cost-effective alternative products can be a challenging task for the global automated immunoassay analyzers industry growth. Apart from this, the medical device performs all the test selection even if not required and this has proved to be time-consuming and expensive for the consumers, thereby adversely impacting its demand as well as sales.  

Automated Immunoassay Analyzers Market: Segmentation

The global automated immunoassay analyzers market is sectored into sales model, technology, end-user, and region.  

In technology terms, the global automated immunoassay analyzers market is segregated into enzyme-linked fluorescent immunoassay (ELFA), radioimmunoassay (RIA), chemiluminescence immunoassay (CLIA), and enzyme-linked immunosorbent assay (ELISA) segments. In addition to this, the chemiluminescence immunoassay (CLIA) segment, which garnered nearly 59% of the global market share in 2022, is projected to record the fastest CAGR in the upcoming years. The growth of the segment in the ensuing years can be due to its growing accuracy of diagnosis through the use of low analytes. Moreover, the technology is reliable and can effectively determine over a hundred analytes each hour.

Based on end-user, the global automated immunoassay analyzers industry is bifurcated into diagnostic laboratories, hospitals, and blood bank segments. In addition to this, the hospital segment, which contributed majorly towards the global industry share in 2022, is set to establish segmental dominance in the upcoming years. The segmental elevation over the assessment timeframe can be due to an increase in the use of automated immunoassay analyzers by physicians in hospitals for monitoring the various kinds of diseases in patients.

On the basis of the sales model, the global automated immunoassay analyzers market is divided into outright sale and reagent rental/lease segments. 

Automated Immunoassay Analyzers Market: Report Scope

Automated Immunoassay Analyzers Market: Regional Insights

North America is likely to set up a dominant status in the global market over 2023-2030

North America, which accounted for half of the global automated immunoassay analyzers market share in 2022, will be the leading region during the forecast period. Moreover, the rise in the use of the product in disease diagnosis, drug monitoring, clinical pharmacokinetics, drug efficiency, and pharmacodynamics will steer the regional market trends. Escalating the occurrence of chronic disorders such as cancers has translated into huge demand for the product in the countries such as the U.S., thereby steering the growth of the market size in the region. Rise in the heart disorders will further contribute to the regional market revenue.  

The Asia-Pacific automated immunoassay analyzers industry is set to register the highest CAGR over the forecast timeline owing to the presence of a large patient population pool in countries such as India and China. Apart from this, the presence of giant participants in these countries will further contribute to the regional industry expansion over the upcoming years In addition to this, countries such as Japan, South Korea, and Taiwan are likely to be the major regional revenue drivers over the coming years.  

Automated Immunoassay Analyzers Market: Competitive Space

The global automated immunoassay analyzers market profiles key players such as:

• BioRad Laboratories
• Roche Diagnostics AG
• Siemens Healthcare
• Carolina Liquid Chemistries Corporation
• Ortho Clinical Diagnostics Corporation
• Meril Life Sciences
• Becton Dickinson and Company
• Luminex Corporation
• Abbott Laboratories
• Randox Laboratories
• BioMerieux S.A.
• Arlington Scientific
• Aesku Diagnostics

The global automated immunoassay analyzers market is segmented as follows:

By Device Type

• Outright Sale
•  Reagent Rental/Lease

By End-User

• Diagnostic Laboratories
• Hospitals
• Blood Bank

By Technology

• Enzyme-Linked Fluorescent Immunoassay (ELFA)
•  Chemiluminescence Immunoassay (CLIA)
• Radioimmunoassay (RIA)
•  Enzyme-Linked Immunosorbent Assay (ELISA)

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa